{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:42:45Z","timestamp":1791286965109,"version":"4.1.0"},"reference-count":49,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.3892\/ijo.2012.1744","type":"journal-article","created":{"date-parts":[[2012,12,18]],"date-time":"2012-12-18T10:26:44Z","timestamp":1355826404000},"page":"478-506","source":"Crossref","is-referenced-by-count":118,"title":["Molecular features of triple negative breast cancer cells by genome-wide gene expression profiling analysis"],"prefix":"10.3892","volume":"42","author":[{"given":"MASATO","family":"KOMATSU","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TETSURO","family":"YOSHIMARU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TAISUKE","family":"MATSUO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KAZUMA","family":"KIYOTANI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YASUO","family":"MIYOSHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TOSHIHITO","family":"TANAHASHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KAZUHITO","family":"ROKUTAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RUI","family":"YAMAGUCHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AYUMU","family":"SAITO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SEIYA","family":"IMOTO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SATORU","family":"MIYANO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YUSUKE","family":"NAKAMURA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MITSUNORI","family":"SASA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MITSUO","family":"SHIMADA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TOYOMASA","family":"KATAGIRI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2012,12,18]]},"reference":[{"key":"key20180107181103_b1-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer Statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"key20180107181103_b2-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrclinonc.2009.234","article-title":"Management breast cancer with targeted agents: importance of heterogeneity","volume":"7","author":"Di Cosimo","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"key20180107181103_b3-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0065-230X(09)03003-6","article-title":"The TRAIL to targeted therapy of breast cancer","volume":"103","author":"Rahman","year":"2009","journal-title":"Adv Cancer Res"},{"key":"key20180107181103_b4-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(07)60028-2","article-title":"HERA study team: 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial","volume":"369","author":"Smith","year":"2007","journal-title":"Lancet"},{"key":"key20180107181103_b5-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJMoa052122","article-title":"Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer","volume":"353","author":"Romond","year":"2005","journal-title":"N Engl J Med"},{"key":"key20180107181103_b6-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa053028","article-title":"Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer","volume":"354","author":"Joensuu","year":"2006","journal-title":"N Engl J Med"},{"key":"key20180107181103_b7-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1056\/NEJMra1001389","article-title":"Triple-negative breast cancer","volume":"363","author":"Foulkes","year":"2010","journal-title":"N Engl J Med"},{"key":"key20180107181103_b8-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1200\/JCO.2007.14.4147","article-title":"Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer","volume":"26","author":"Liedtke","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20180107181103_b9-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/ng1029","article-title":"Medical applications of microarray technologies: a regulatory science perspective","volume":"32","author":"Petricoin","year":"2002","journal-title":"Nat Genet"},{"key":"key20180107181103_b10-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources","volume":"4","author":"Huang","year":"2009","journal-title":"Nat Protoc"},{"key":"key20180107181103_b11-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkn923","article-title":"Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists","volume":"37","author":"Huang","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"key20180107181103_b12-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/path.2668","article-title":"A five-gene signature as a potential predictor of metastasis and survival in colorectal cancer","volume":"220","author":"Hao","year":"2010","journal-title":"J Pathol"},{"key":"key20180107181103_b13-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"8752","DOI":"10.1158\/0008-5472.CAN-09-1809","article-title":"Ubiquitination and downregulation of BRCA1 by ubiquitin-conjugating enzyme E2T overexpression in human breast cancer cells","volume":"69","author":"Ueki","year":"2009","journal-title":"Cancer Res"},{"key":"key20180107181103_b14-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/sj.bjc.6605122","article-title":"Validation of UBE2C protein as a prognostic marker in node-positive breast cancer","volume":"101","author":"Loussouarn","year":"2009","journal-title":"Br J Cancer"},{"key":"key20180107181103_b15-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00726-010-0496-4","article-title":"S100P: a novel therapeutic target for cancer","volume":"41","author":"Arumugam","year":"2011","journal-title":"Amino Acids"},{"key":"key20180107181103_b16-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"e29783","DOI":"10.1371\/journal.pone.0029783","article-title":"The ubiquitin peptidase UCHL1 induces G0\/G1 cell cycle arrest and apoptosis through stabilizing p53 and is frequently silenced in breast cancer","volume":"7","author":"Xiang","year":"2012","journal-title":"PLoS One"},{"key":"key20180107181103_b17-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"19516","DOI":"10.1074\/jbc.M111.337428","article-title":"PTTG1 oncogene promotes tumor malignancy via epithelial to mesenchymal transition and expansion of cancer stem cell population","volume":"287","author":"Yoon","year":"2012","journal-title":"J Biol Chem"},{"key":"key20180107181103_b18-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10549-009-0683-8","article-title":"UHRF1 inhibits MDR1 gene transcription and sensitizes breast cancer cells to anticancer drugs","volume":"124","author":"Jin","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"key20180107181103_b19-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"22245","DOI":"10.1074\/jbc.M002446200","article-title":"Cell cycle-regulated phosphorylation of the human SIX1 homeodomain protein","volume":"275","author":"Ford","year":"2000","journal-title":"J Biol Chem"},{"key":"key20180107181103_b20-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1349-7006.2006.00381.x","article-title":"Elevated expression of protein regulator of cytokinesis 1, involved in the growth of breast cancer cells","volume":"98","author":"Shimo","year":"2007","journal-title":"Cancer Sci"},{"key":"key20180107181103_b21-ijo-42-02-0478","first-page":"179","article-title":"Topoisomerase II alpha as a marker predicting the efficacy of anthracyclines in breast cancer: are we at the end of the beginning?","volume":"4","author":"Di Leo","year":"2003","journal-title":"Clin Breast Cancer"},{"key":"key20180107181103_b22-ijo-42-02-0478","first-page":"2389","article-title":"Expression of p53, Ki-67, E-cadherin, N-cadherin and TOP2A in triple-negative breast cancer","volume":"31","author":"Nakagawa","year":"2011","journal-title":"Anticancer Res"},{"key":"key20180107181103_b23-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"11565","DOI":"10.1158\/0008-5472.CAN-07-2536","article-title":"Integrated profiling of basal and luminal breast cancers","volume":"67","author":"Ad\u00e9la\u00efde","year":"2007","journal-title":"Cancer Res"},{"key":"key20180107181103_b24-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.ajpath.2010.11.075","article-title":"Association of FABP5 expression with poor survival in triple-negative breast cancer: implication for retinoic acid therapy","volume":"178","author":"Liu","year":"2011","journal-title":"Am J Pathol"},{"key":"key20180107181103_b25-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"9402","DOI":"10.1158\/0008-5472.CAN-10-1199","article-title":"ANCCA\/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2","volume":"70","author":"Kalashnikova","year":"2010","journal-title":"Cancer Res"},{"key":"key20180107181103_b26-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1158\/1078-0432.CCR-10-0889","article-title":"Clinical implications of gene dosage and gene expression patterns in diploid breast carcinoma","volume":"16","author":"Parris","year":"2010","journal-title":"Clin Cancer Res"},{"key":"key20180107181103_b27-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/carcin\/bgi379","article-title":"Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer","volume":"27","author":"Ai","year":"2006","journal-title":"Carcinogenesis"},{"key":"key20180107181103_b28-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1158\/0008-5472.CAN-08-3615","article-title":"SCUBE2 suppresses breast tumor cell proliferation and confers a favorable prognosis in invasive breast cancer","volume":"69","author":"Cheng","year":"2009","journal-title":"Cancer Res"},{"key":"key20180107181103_b29-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1349-7006.2008.01007.x","article-title":"Nek2 as a novel molecular target for the treatment of breast carcinoma","volume":"100","author":"Tsunoda","year":"2009","journal-title":"Cancer Sci"},{"key":"key20180107181103_b30-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1349-7006.2010.01504.x","article-title":"Novel combination treatment for colorectal cancer using Nek2 siRNA and cisplatin","volume":"101","author":"Suzuki","year":"2010","journal-title":"Cancer Sci"},{"key":"key20180107181103_b31-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"9186","DOI":"10.1158\/0008-5472.CAN-06-1601","article-title":"PDZ-binding kinase\/T-LAK cell-originated protein kinase, a putative cancer\/testis antigen with an oncogenic activity in breast cancer","volume":"66","author":"Park","year":"2006","journal-title":"Cancer Res"},{"key":"key20180107181103_b32-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"5672","DOI":"10.1038\/onc.2008.186","article-title":"Involvement of elevated expression of multiple cell-cycle regulator, DTL\/RAMP (denticleless\/RA-regulated nuclear matrix associated protein), in the growth of breast cancer cells","volume":"27","author":"Ueki","year":"2008","journal-title":"Oncogene"},{"key":"key20180107181103_b33-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"R17","DOI":"10.1186\/bcr1650","article-title":"Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 family","volume":"9","author":"Lin","year":"2007","journal-title":"Breast Cancer Res"},{"key":"key20180107181103_b34-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1349-7006.2007.00635.x","article-title":"Involvement of kinesin family member 2C\/mitotic centromere-associated kinesin overexpression in mammary carcinogenesis","volume":"99","author":"Shimo","year":"2008","journal-title":"Cancer Sci"},{"key":"key20180107181103_b35-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/ijc.25698","article-title":"The ECM protein LTBP-2 is a suppressor of esophageal squamous cell carcinoma tumor formation but higher tumor expression associates with poor patient outcome","volume":"129","author":"Chan","year":"2011","journal-title":"Int J Cancer"},{"key":"key20180107181103_b36-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1158\/0008-5472.CAN-03-0701","article-title":"Molecular detection of noninvasive and invasive bladder tumor tissues and exfoliated cells by aberrant promoter methylation of laminin-5 encoding genes","volume":"64","author":"Sathyanarayana","year":"2004","journal-title":"Cancer Res"},{"key":"key20180107181103_b37-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"e15612","DOI":"10.1371\/journal.pone.0015612","article-title":"Differential expression of CHL1 gene during development of major human cancers","volume":"6","author":"Senchenko","year":"2011","journal-title":"PLoS One"},{"key":"key20180107181103_b38-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1126\/science.283.5408.1733","article-title":"Abnormal spindle protein, Asp, and the integrity of mitotic centrosomal microtubule organizing centers","volume":"283","author":"do Carmo Avides","year":"1999","journal-title":"Science"},{"key":"key20180107181103_b39-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1091\/mbc.E07-10-1051","article-title":"KNL1 and the CENP-H\/I\/K complex coordinately direct kinetochore assembly in vertebrates","volume":"19","author":"Cheeseman","year":"2008","journal-title":"Mol Biol Cell"},{"key":"key20180107181103_b40-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.canlet.2005.06.017","article-title":"Nek2 kinase in chromosome instability and cancer","volume":"237","author":"Hayward","year":"2006","journal-title":"Cancer Lett"},{"key":"key20180107181103_b41-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/jnr.21471","article-title":"Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells","volume":"86","author":"Nakano","year":"2008","journal-title":"J Neurosci Res"},{"key":"key20180107181103_b42-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"E87","DOI":"10.1111\/j.1365-2559.2012.04195.x","article-title":"Epithelial-mesenchymal transition in breast cancer correlates with high histological grade and triple-negative phenotype","volume":"60","author":"Jeong","year":"2012","journal-title":"Histopathology"},{"key":"key20180107181103_b43-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"17402","DOI":"10.1073\/pnas.0608396103","article-title":"Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target","volume":"103","author":"Horvath","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107181103_b44-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1073\/pnas.77.3.1627","article-title":"Autoantibody to centromere (kinetochore) in scleroderma sera","volume":"77","author":"Moroi","year":"1980","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107181103_b45-ijo-42-02-0478","first-page":"3511","article-title":"Overexpression and mistargeting of centromere protein-A in human primary colorectal cancer","volume":"63","author":"Tomonaga","year":"2003","journal-title":"Cancer Res"},{"key":"key20180107181103_b46-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/1097-0347(200102)23:2<104::AID-HED1005>3.0.CO;2-0","article-title":"CENP-F gene amplification and overexpression in head and neck squamous cell carcinomas","volume":"23","author":"de la Guardia","year":"2001","journal-title":"Head Neck"},{"key":"key20180107181103_b47-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1593\/neo.04295","article-title":"Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarrays","volume":"6","author":"Gr\u00fctzmann","year":"2004","journal-title":"Neoplasia"},{"key":"key20180107181103_b48-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1476-4598-10-23","article-title":"Expression analysis of mitotic spindle checkpoint genes in breast carcinoma: role of NDC80\/HEC1 in early breast tumorigenicity, and a two-gene signature for aneuploidy","volume":"10","author":"Bi\u00e8che","year":"2011","journal-title":"Mol Cancer"},{"key":"key20180107181103_b49-ijo-42-02-0478","doi-asserted-by":"crossref","first-page":"R18","DOI":"10.1186\/bcr2487","article-title":"The expression level of HJURP has an independent prognostic impact and predicts the sensitivity to radiotherapy in breast cancer","volume":"12","author":"Hu","year":"2010","journal-title":"Breast Cancer Res"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2012.1744\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T12:52:51Z","timestamp":1714740771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2012.1744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,18]]},"references-count":49,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,12,18]]},"published-print":{"date-parts":[[2013,2]]}},"alternative-id":["10.3892\/ijo.2012.1744"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2012.1744","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,18]]}}}